Narrow your search

Library

KU Leuven (7)

ULB (5)

ULiège (5)

Odisee (4)

Thomas More Kempen (4)

Thomas More Mechelen (4)

UCLL (4)

VIVES (4)

LUCA School of Arts (3)

UGent (2)

More...

Resource type

book (9)

periodical (2)

article (1)


Language

English (12)


Year
From To Submit

2020 (4)

2011 (1)

2006 (1)

2005 (1)

2001 (1)

More...
Listing 1 - 10 of 12 << page
of 2
>>
Sort by

Article
Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family
Author:
Year: 2001

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Cyclic nucleotides
Authors: --- ---
ISBN: 354010786X 3642681131 3642681115 3540112391 Year: 1982 Volume: 58 Publisher: Berlin Springer

Loading...
Export citation

Choose an application

Bookmark

Abstract

Laughing gas, Viagra, and Lipitor
Author:
ISBN: 0197562396 1280965789 0195345762 1429420340 9780195345766 9781280965784 9781429420341 9786610965786 6610965781 0195300998 9780195300994 0199885281 Year: 2006 Publisher: Oxford New York Oxford University Press

Loading...
Export citation

Choose an application

Bookmark

Abstract

The stories behind drug discovery are fascinating, full of human and scientific interest. This is a book on the history of drug discovery that highlights the intellectual splendor of discoverers as well as the human frailty associated with them. History is replete with examples of breakthrough medicines that have saved millions of lives. Ether as an anesthetic by Morton; penicillin as an antibiotic by Fleming; and insulin as an anti-diabetic by Banting are just a few examples. The discoverers of these medicines are doubtlessly benefactors to mankind - for instance, without penicillin, 75% of us probably would not be alive because some of our parents or grandparents would have succumbed to infections. The text is supplemented by many anecdotes, pictures and postage stamps.

Oral pharmacotherapy for male sexual dysfunction : a guide to clinical management
Author:
ISBN: 9781588294517 158829451X 9781592598717 9786610359455 1280359455 1592598714 Year: 2005 Publisher: Totowa, N.J. : Humana Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

With the advent of such oral drugs as Viagra®, Cialis®, and Levitra® for the treatment of erectile dysfunction (ED), the burden of first patient evaluation has fallen on the primary care provider. In Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management, highly experienced urologists and physician researchers review each aspect of male sexual dysfunction (interest, performance, and orgasm) and their implications for treatment. The authors address a wide variety of clinical issues, ranging from common medical risk factors for ED to the evaluation and management of men who have atypical presentations that require focused testing; from diabetic ED to the safety assessment of PDE inhibitors for cardiac patients; and from combination drug therapy for refractory patients to neuropharmacological therapies. Guidance is also provided for vacuum erection devices and surgical implants, the role of self-medication with dietary supplements, the management of post-prostatectomy ED, and the emerging pharmaceutical therapies for rapid ejaculation. On the pharmaceutical side, the authors summarize the pharmacology and development of PDE-type 5 inhibitors, review the preclinical data and 5 years of postmarketing data on Viagra®, examine the preclinical data on Levitra®, and discuss the design and conduct of US clinical trials of Cialis®. Authoritative and informative, Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management clarifies for urologists, family physicians, and internists each of the diagnostic approaches to male sexual dysfunction, as well as the pharmacological strategies available for its safe and effective management.


Book
The molecular switch : signaling and allostery
Authors: ---
ISBN: 0691200254 Year: 2020 Publisher: Princeton, New Jersey ; Oxford : Oxford Princeton University Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

A signature feature of living organisms is their ability to carry out purposeful actions by taking stock of the world around them. To that end, cells have an arsenal of signaling molecules linked together in signaling pathways, which switch between inactive and active conformations. The Molecular Switch articulates a biophysical perspective on signaling, showing how allostery—a powerful explanation of how molecules function across all biological domains—can be reformulated using equilibrium statistical mechanics, applied to diverse biological systems exhibiting switching behaviors, and successfully unify seemingly unrelated phenomena.Rob Phillips weaves together allostery and statistical mechanics via a series of biological vignettes, each of which showcases an important biological question and accompanying physical analysis. Beginning with the study of ligand-gated ion channels and their role in problems ranging from muscle action to vision, Phillips then undertakes increasingly sophisticated case studies, from bacterial chemotaxis and quorum sensing to hemoglobin and its role in mammalian physiology. He looks at G-protein coupled receptors as well as the role of allosteric molecules in gene regulation. Phillips concludes by surveying problems in biological fidelity and offering a speculative chapter on the relationship between allostery and biological Maxwell demons.Appropriate for graduate students and researchers in biophysics, physics, engineering, biology, and neuroscience, The Molecular Switch presents a unified, quantitative model for describing biological signaling phenomena.


Book
Phosphodiesterases as drug targets
Authors: --- ---
ISBN: 9783642179693 9783642179686 3642179681 364217969X Year: 2011 Publisher: New York : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Cyclic nucleotide phosphodiesterases (PDEs) are promising targets for pharmacological intervention. Multiple PDE genes, isoform diversity, selective expression and compartmentation of the isoforms, and an array of conformations of PDE proteins are properties that challenge development of drugs that selectively target this class of enzymes. Novel characteristics of PDEs are viewed as unique opportunities to increase specificity and selectivity when designing novel compounds for certain therapeutic indications. This chapter provides a summary of the major concepts related to the design and use of PDE inhibitors.

Keywords

Chemical structure --- cytologie --- Clinical chemistry --- biochemie --- Histology. Cytology --- moleculaire structuur --- General biochemistry --- biosynthese --- genetische manipulatie --- massaspectrometrie --- toxicologie --- polypeptiden --- aminozuren --- eiwitten --- Pharmacology. Therapy --- medische chemie --- Organic spectroscopy --- Cyclic nucleotide phosphodiesterases. --- Drug targeting. --- Toxicology. --- Biochemistry. --- Enzymes. --- Post-translational modification . --- Cell physiology. --- Pharmacology/Toxicology. --- Medicinal Chemistry. --- Protein Structure. --- Enzymology. --- Posttranslational Modification. --- Cell Physiology. --- Cell function --- Cytology --- Physiology --- Co-translational modification --- Cotranslational modification --- Modification, Post-translational --- Post-translation protein modification --- Post-translational protein modification --- Posttranslation protein modification --- Posttranslational modification --- Posttranslational protein modification --- Genetic translation --- Proteins --- Biocatalysts --- Ferments --- Soluble ferments --- Catalysts --- Enzymology --- Biological chemistry --- Chemical composition of organisms --- Organisms --- Physiological chemistry --- Biology --- Chemistry --- Medical sciences --- Chemicals --- Medicine --- Pharmacology --- Poisoning --- Poisons --- Synthesis --- Composition --- Toxicology --- Pharmacology. --- Medicinal chemistry. --- Proteins . --- Posttranslational modification. --- Biochemistry --- Enzymes --- Proteids --- Biomolecules --- Polypeptides --- Proteomics --- Chemistry, Medical and pharmaceutical --- Chemistry, Pharmaceutical --- Drug chemistry --- Drugs --- Medical chemistry --- Medicinal chemistry --- Pharmacochemistry --- Drug effects --- Medical pharmacology --- Chemotherapy --- Pharmacy --- Physiological effect --- Phosphodiesterases. --- Analysis.


Book
Radiolabelled Molecules for Brain Imaging with PET and SPECT
Author:
Year: 2020 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are in vivo molecular imaging methods which are widely used in nuclear medicine for diagnosis and treatment follow-up of many major diseases. These methods use target-specific molecules as probes, which are labeled with radionuclides of short half-lives that are synthesized prior to the imaging studies. These probes are called radiopharmaceuticals. The use of PET and SPECT for brain imaging is of special significance since the brain controls all the body’s functions by processing information from the whole body and the outside world. It is the source of thoughts, intelligence, memory, speech, creativity, emotion, sensory functions, motion control, and other important body functions. Protected by the skull and the blood–brain barrier, the brain is somehow a privileged organ with regard to nutrient supply, immune response, and accessibility for diagnostic and therapeutic measures. Invasive procedures are rather limited for the latter purposes. Therefore, noninvasive imaging with PET and SPECT has gained high importance for a great variety of brain diseases, including neurodegenerative diseases, motor dysfunctions, stroke, epilepsy, psychiatric diseases, and brain tumors. This Special Issue focuses on radiolabeled molecules that are used for these purposes, with special emphasis on neurodegenerative diseases and brain tumors.

Listing 1 - 10 of 12 << page
of 2
>>
Sort by